Lonza receives EU approval to buy Capsugel
MLex Summary: Lonza Group has received EU clearance to buy drug-capsule maker Capsugel for $5.5 billion. The European Commission today said it had approved the deal, noting that the companies' activities...To view the full article, register now.
Already a subscriber? Click here to view full article